Program Milestone: Post-Trial Supply

What Do Oman, Pakistan, Lebanon, India, and Jordan Have in Common?

When a clinical trial at a hospital in Lebanon concluded, eight pediatric patients were receiving treatment through the program.

Only two of those patients lived in Lebanon. For the remaining six children, continuing care suddenly became far more complicated.

Living in India, Oman, Pakistan, and Jordan, regular travel to Lebanon was no longer a practical—or sustainable—option. What began as a clinical challenge quickly became a continuity-of-care challenge.

Because these were pediatric patients, treatment-related travel involved both the child and a caregiver, significantly increasing the burden on families. Once the clinical trial ended, sponsor-funded travel support was no longer available. Without an alternative solution, there was a real risk of interruptions in treatment.

Building a Path Forward

Working closely with the investigator in Lebanon, Tanner developed a transition plan centered on one goal: ensuring every patient could continue receiving therapy closer to home.

Achieving that goal required identifying qualified local physicians in each patient's country, establishing new treatment sites, and building relationships with healthcare providers and institutions that were entirely new to the program.

The process was far from simple. Language barriers, varying regulatory requirements, and limited local infrastructure created challenges at every step.

To navigate these complexities, we partnered with a regional Patient Advocacy Group whose local expertise helped us connect with healthcare providers, understand country-specific requirements, and accelerate patient transitions.

Coordinating Across Borders

Over the following weeks, teams across multiple countries worked together to onboard physicians, establish treatment sites, provide program training, and support the regulatory processes required to import and administer treatment locally.

The result was clear: every patient was successfully transitioned to local care.

Treatment continued without interruption, ensuring all eight children maintained access to the therapy they depended on.

Lessons in Continuity of Care

This project demonstrates how patient-focused planning, cross-border coordination, and strong local partnerships can overcome geographic barriers and help ensure continuity of care when clinical trials come to an end.

Post-trial access remains one of the most complex phases of the patient journey. Yet with the right strategy, collaboration, and local expertise, it is possible to ensure patients continue receiving the care they need—regardless of where they live.

If you're navigating similar challenges, we'd love to connect and share what we've learned.

Let's talk about what we can do for you.